Paper Details

  1. Home
  2. Paper Details

Irritable colon syndrome treated with an antispasmodic drug.

Author:

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Dicyclomine was found to have therapeutic effects in comparison to placebo, showing statistically significant differences.
Paper Details　
Original Abstract of the Article :
It was concluded that the trial had demonstrated therapeutic effects from dicyclomine in comparison with the placebo. Thus, the differences recorded, some of which were statistically significant, were all in favour of the active drug, despite the fact that a carry-over effect was apparent in the pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/787960

データ提供：米国国立医学図書館（NLM）

Dicyclomine: A Potential Relief for Irritable Colon Syndrome

Irritable colon syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits. This research investigates the effectiveness of dicyclomine, an antispasmodic drug, in treating IBS. The researchers conducted a trial comparing dicyclomine to a placebo to determine its impact on IBS symptoms.

Dicyclomine Shows Promise for IBS Relief

The trial demonstrated therapeutic effects from dicyclomine compared to the placebo, suggesting that this drug could be a viable option for managing IBS symptoms. While a carry-over effect was observed in patients who received dicyclomine first, the differences recorded, some of which were statistically significant, all favored the active drug. This suggests that dicyclomine could be a beneficial treatment for IBS, although further research is needed to confirm its long-term effectiveness and identify optimal dosage regimens.

Finding Relief for IBS: A Constant Search

This study provides a glimpse of hope for individuals struggling with IBS. It's like finding a cool breeze in a scorching desert – a moment of relief from the discomfort of IBS symptoms.

Dr.Camel's Conclusion

This research suggests that dicyclomine could be a valuable option for treating IBS symptoms. It’s like discovering a new, refreshing oasis in the desert – a source of potential relief for those struggling with IBS.

Date :
  1. Date Completed 1976-12-01
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

787960

DOI: Digital Object Identifier

787960

Related Literature

Article Analysis
・Effects of dicyclomine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.